-
[1]
Kai Lin, 2010: Development of Novel Antiviral Therapies for Hepatitis C Virus, Virologica Sinica, 25, 246-266. doi: 10.1007/s12250-010-3140-2
-
[2]
Pinghu Zhang, Shuo Zhai, Jinhong Chang, Ju-Tao Guo, 2018: In Vitro Anti-hepatitis B Virus Activity of 2', 3'-Dideoxyguanosine, Virologica Sinica, 33, 538-544. doi: 10.1007/s12250-018-0065-7
-
[3]
You-hua XIE, Ran HONG, Wei LIU, Jing LIU, Jian-wei ZHAI, 2010: Development of Novel Therapeutics for Chronic Hepatitis B*, Virologica Sinica, 25, 294-300. doi: 10.1007/s12250-010-3138-9
-
[4]
Jun Luo, Yue Zhang, Yang Wang, Qing Liu, Jiesen Li, Hongling He, Yongwen Luo, Shile Huang, Xiaofeng Guo, 2021: Artesunate and Dihydroartemisinin Inhibit Rabies Virus Replication, Virologica Sinica, 36, 721-729. doi: 10.1007/s12250-021-00349-z
-
[5]
Yang-fei XIANG, Ying PEI, Yi-fei WANG, 2008: Current Status of Natural Products from Plants as Anti-herpes Simplex Virus 1 Agents, Virologica Sinica, 23, 305-314. doi: 10.1007/s12250-008-2962-7
-
[6]
Yue Wang, Huimin Huang, Dongliang Li, Chenxu Zhao, Shuai Li, Panpan Qin, Yaqin Li, Xia Yang, Wenjuan Du, Wentao Li, Yongtao Li, 2023: Identification of niclosamide as a novel antiviral agent against porcine epidemic diarrhea virus infection by targeting viral internalization, Virologica Sinica, 38, 296-308. doi: 10.1016/j.virs.2023.01.008
-
[7]
Lizhan Su, Yarou Gao, Mingxin Zhang, Zexin Liu, Qisheng Lin, Lang Gong, Jianying Guo, Lixia Chen, Tongqing An, Jianxin Chen, 2021: Andrographolide and Its Derivative Potassium Dehydrographolide Succinate Suppress PRRSV Replication in Primary and Established Cells via Differential Mechanisms of Action, Virologica Sinica, 36, 1626-1643. doi: 10.1007/s12250-021-00455-y
-
[8]
Na Li, Zhen Wang, Rui Wang, Zhe-Rui Zhang, Ya-Nan Zhang, Cheng-Lin Deng, Bo Zhang, Lu-Qing Shang, Han-Qing Ye, 2021: In Vitro Inhibition of Alphaviruses by Lycorine, Virologica Sinica, 36, 1465-1474. doi: 10.1007/s12250-021-00438-z
-
[9]
Weizhi Lu, Linjuan Shi, Jing Gao, Huimin Zhu, Ying Hua, Jintai Cai, Xianbo Wu, Chengsong Wan, Wei Zhao, Zhang Bao, 2021: Piperlongumine Inhibits Zika Virus Replication In vitro and Promotes Up-Regulation of HO-1 Expression, Suggesting An Implication of Oxidative Stress, Virologica Sinica, 36, 510-520. doi: 10.1007/s12250-020-00310-6
-
[10]
Zherui Zhang, Hongqing Zhang, Yanan Zhang, Qiuyan Zhang, Qiaojie Liu, Yanyan Hu, Xiaoling Chen, Jing Wang, Yujia Shi, Chenglin Deng, Peng Gong, Bo Zhang, Xiaodan Li, Bing Zhu, Hanqing Ye, 2023: Oridonin inhibits SARS-CoV-2 replication by targeting viral proteinase and polymerase, Virologica Sinica, 38, 470-479. doi: 10.1016/j.virs.2023.04.008
-
[11]
Meiyue Dong, Yanyan Wang, Ping Li, Zinuo Chen, Varada Anirudhan, Qinghua Cui, Lijun Rong, Ruikun Du, 2023: Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor, Virologica Sinica, 38, 931-939. doi: 10.1016/j.virs.2023.09.003
-
[12]
Dong-Peng Wang, Hong-Yan Zhang, Bo-Wei Liao, Zhen Tong, Zhi-Sheng Xu, Yan-Yi Wang, Yan Yang, 2021: SRP54 Negatively Regulates IFN-Beta Production and Antiviral Response by Targeting RIG-I and MDA5, Virologica Sinica, 36, 231-240. doi: 10.1007/s12250-020-00267-6
-
[13]
Xiaojie Zheng, Shengming Nie, Wen-Hai Feng, 2022: Regulation of antiviral immune response by African swine fever virus (ASFV), Virologica Sinica, 37, 157-167. doi: 10.1016/j.virs.2022.03.006
-
[14]
Junwen Zheng, Pu Yang, Yan Tang, Dongchi Zhao, 2015: A respiratory syncytial virus persistent-infected cell line system reveals the involvement of SOCS1 in the innate antiviral response, Virologica Sinica, 30, 190-199. doi: 10.1007/s12250-015-3597-0
-
[15]
Xia Zhai, Shuo Wu, Lexun Lin, Tianying Wang, Xiaoyan Zhong, Yang Chen, Weizhen Xu, Lei Tong, Yan Wang, Wenran Zhao, Zhaohua Zhong, 2018: Stress Granule Formation is One of the Early Antiviral Mechanisms for Host Cells Against Coxsackievirus B Infection, Virologica Sinica, 33, 314-322. doi: 10.1007/s12250-018-0040-3
-
[16]
Song Hu, Fahu Yuan, Lingyan Feng, Fang Zheng, Feili Gong, Hanju Huang, Binlian Sun, 2018: KIR2DL2/C1 is a Risk Factor for Chronic Infection and Associated with Non-response to PEG-IFN and RBV Combination Therapy in Hepatitis C Virus Genotype 1b Patients in China, Virologica Sinica, 33, 369-372. doi: 10.1007/s12250-018-0042-1
-
[17]
罗端德, 王心禾, 蔡淑清, 刘世威, 韦克奇, 夏金生, 常泉海, 郑继英, 范木生, 1988: Studies on Antiviral Therapy of Epidemic Hemorrhagic Fever, Virologica Sinica, 3, 290-.
-
[18]
Lok-Yin Roy Wong, Pak-Yin Lui, Dong-Yan Jin, 2016: A molecular arms race between host innate antiviral response and emerging human coronaviruses, Virologica Sinica, 31, 12-23. doi: 10.1007/s12250-015-3683-3
-
[19]
Qiuyan Zhang, Na Li, Chenglin Deng, Zherui Zhang, Xiaodan Li, Kentaro Yoshii, Hanqing Ye, Bo Zhang, 2019: Trans Complementation of Replication-defective Omsk Hemorrhagic Fever Virus for Antiviral Study, Virologica Sinica, 34, 412-422. doi: 10.1007/s12250-019-00109-0
-
[20]
Tao PENG, 2010: Strategies for Antiviral Screening Targeting Early Steps of Virus Infection*, Virologica Sinica, 25, 281-293. doi: 10.1007/s12250-010-3135-z